证券代码：873122 证券简称：中纺标 公告编号：2023-034 中纺标检验认证股份有限公司 2022 年年度股东大会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2023 年 5 月 18 日 2.会议召开地点：公司会议室 3.会议召开方式：现场投票和网络投票相结合方式 4.会议召集人：董事会 5.会议主持人：董事长马咏梅女士 6.召开情况合法、合规、合章程性说明： 本次股东大会的召集、召开、议案审议及表决程序符合《公司法》等有关法 律、法规及《公司章程》的规定。 （二）会议出席情况 出席和授权出席本次股东大会的股东共 36 人，持有表决权的股份总数 70,786,908 股，占公司有表决权股份总数的 76.58%。 其中通过网络投票参与本次股东大会的股东共 35 人，持有表决权的股份总数 16,786,908 股，占公司有表决权股份总数的 18.16%。 （三）公司董事、监事、高级管理人员出席或列席股东大会情况 1.公司在 ...

证券代码：873122 证券简称：中纺标 公告编号：2023-033 中纺标检验认证股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责。 □其他（请文字说明其他活动内容） 一、投资者关系活动类别 □特定对象调研 业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 二、投资者关系活动情况 （一）活动时间、地点 中纺标检验认证股份有限公司（以下简称"公司"）于 2023 年 5 月 17 日下午 15:00-17:00 通过全景网"投资者关系互动平台"（https://ir.p5w.net）采用网络远程的 方式，召开了 2022 年年度报告业绩说明会。 （二）参与单位及人员 通过网络方式参加公司 2022 年年度报告业绩说明会的投资者。 （三）上市公司接待人员 公司董事、总经理：李斌先生 公司董事、财务总监、董事会秘书：牛艳花女士 公司保荐代表人：徐鸿宇先生 三、投资者关系活动主要内容 本次年度报告业绩说明会通过年报视频解读等形式对公司概况及 2022 年 ...

（一）会议召开时间：2023 年 5 月 17 日 15:00-17:00。 （二）会议召开地点 本次年报业绩说明会将采用网络远程的方式举行，投资者可登陆全景网"投 资者关系互动平台"（http://ir.p5w.net）参与本次年报业绩说明会。 三、 参加人员 证券代码：873122 证券简称：中纺标 公告编号：2023-032 中纺标检验认证股份有限公司 2022 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 中纺标检验认证份有限公司（以下简称"公司"）于 2023 年 4 月 27 日在北京 证券交易所指定信息披露平台（www.bse.cn）披露了《2022 年年度报告》，为方 便广大投资者更深入了解公司 2022 年年度经营业绩的具体情况，加强与投资者 的互动交流，公司拟召开 2022 年年度报告业绩说明会。 二、 说明会召开的时间、地点 公司董事、总经理：李斌先生 公司董事、财务总监、董事会秘书：牛艳花女士 公司保荐代表人：徐鸿宇先生 四、 投 ...

证券代码：873122 证券简称：中纺标 公告编号：2023-032 中纺标检验认证股份有限公司 2022 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 公司保荐代表人：徐鸿宇先生 四、 投资者参加方式 本次说明会采用网络方式召开。 中纺标检验认证份有限公司（以下简称"公司"）于 2023 年 4 月 27 日在北京 证券交易所指定信息披露平台（www.bse.cn）披露了《2022 年年度报告》，为方 便广大投资者更深入了解公司 2022 年年度经营业绩的具体情况，加强与投资者 的互动交流，公司拟召开 2022 年年度报告业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：2023 年 5 月 17 日 15:00-17:00。 （二）会议召开地点 本次年报业绩说明会将采用网络远程的方式举行，投资者可登陆全景网"投 资者关系互动平台"（http://ir.p5w.net）参与本次年报业绩说明会。 三、 参加人员 公司董事、总经理：李斌先生 ...

中纺标检验认证股份有限公司 审计报告 众环审字（2023) 0201221 目录 起始页码 审计报告 | 财务报表 | | | --- | --- | | 合并资产负债表 | | | 合并利润表 | 3 | | 合并 企济昼表 | 4 | | 合并股利；对艺思摄 | 5 | | 资产负债表 | 7 | | 利润表 | 9 | | 现企济昼表 | 10 | | 益变动表 | 11 | | 财销员表附注 | 13 | | 财务报表附注补充资料 | 94 | 市企烹 中审武耳垂计师事暨珩（将来吾遇古伙） 武汉市it fl 区草'll 169 号中冒企环大厦 国政局奇的0-077 Zh0<1th• ＂＇·拥•＂＂"'" "''' ,, 的＂＇＇吵 '"d '"'"' ,,,,,;" 传真 Fax: 027 85424329 '＂＇、＂ •x•n 1h ＂＂＇＇唱＇＇＂＇＇＂＂＇何 c" ;"d""'""'""'""'LlP 电话 Tel: 027-86791215 审计报告 众环审字（ 2023) 0201221 中纺标检验认证股份有限公司全体股东： －、审计意见 我们审计了中纺标检验认证股份有限公司（以下简称"中纺 ...

证券代码：873122 证券简称：中纺标 公告编号：2023-025 中纺标检验认证股份有限公司 独立董事关于第二届董事会第二十六次会议相关事项的独立意见 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别 及连带法律责任。 根据《中华人民共和国公司法》《中华人民共和国证券法》《北京证券交易 所上市公司持续监管指引第 1 号——独立董事》《中纺标检验认证股份有限公司 章程》《中纺标检验认证股份有限公司独立董事工作制度》之规定，作为中纺标 检验认证股份有限公司（以下简称"公司"）的独立董事，基于客观、独立判断 的原则，对第二届董事会第二十六次会议所审议的以下议案进行了认真的核查， 并发表如下独立意见： 一、《关于 2022 年年度报告及摘要的议案》的独立意见 我们同意该议案，并将该议案提交公司股东大会审议。 四、《关于 2022 年度权益分派方案的议案》的独立意见 经审阅该议案内容，我们认为，公司董事会提出的 2022 年度利润分配方案， 综合考虑了股东的合理回报与公司业务正常经营以及未来业务发展的资金需要， 分派方案经测算与 ...

Company Achievements and Recognition - Chinatesta successfully listed on the Beijing Stock Exchange on September 27, 2022, becoming the first stock in the textile inspection and testing sector on this exchange[4] - The company achieved recognition as a "Specialized, Refined, Unique, and Innovative" small and medium-sized enterprise in Beijing in December 2022[4] - Chinatesta's efforts in research and development were recognized with three awards from the China National Textile and Apparel Council for technological progress in December 2022[4] - The company is recognized as a "specialized, refined, distinctive, and innovative" enterprise at the provincial level, enhancing its market position[45] - The company has received multiple honors, including "National High-tech Enterprise" and "Quality Integrity Enterprise" in China[91] - Zhongfang Biao (Fujian) Testing Co., Ltd. has been recognized as a "National High-tech Enterprise" in 2022[93] Financial Performance - The company's operating revenue for 2022 was CNY 186,605,173.13, representing a 2.70% increase compared to CNY 181,702,683.30 in 2021[30] - The net profit attributable to shareholders for 2022 was CNY 35,939,579.21, which is a 5.04% increase from CNY 34,215,086.47 in 2021[30] - The gross profit margin decreased to 51.06% in 2022 from 55.38% in 2021[30] - Total assets increased by 26.37% to CNY 380,883,165.71 in 2022, up from CNY 301,406,679.58 in 2021[32] - The company's net cash flow from operating activities was CNY 36,310,429.15, a decrease of 26.03% compared to CNY 49,090,898.92 in 2021[33] - The weighted average return on equity based on net profit attributable to shareholders was 12.66% in 2022, down from 13.85% in 2021[30] - The company's total equity attributable to shareholders increased by 31.36% to CNY 327,771,151.86 in 2022[32] - The basic earnings per share for 2022 was CNY 0.43, a decrease of 4.44% from CNY 0.45 in 2021[30] - The company's inventory turnover rate was 31.83 in 2022, down from 41.55 in 2021[34] - The company reported a net profit of CNY 36,033,662.51, a slight decrease of 0.83% compared to the previous year[62] - The company’s net profit decreased by 0.83% year-on-year, primarily due to revenue growth being slower than the increase in costs and expenses[10] Expansion and Diversification - Chinatesta's registered capital for its newly established Jiangxi branch is 10 million RMB, indicating expansion efforts[4] - The company has initiated a public service platform project for the medical protection field, which successfully passed inspection in October 2022, indicating diversification in service offerings[4] - The company established a wholly-owned subsidiary in Yudu County, Ganzhou City, Jiangxi Province, to enhance its testing base and optimize resource allocation[48] - The company has expanded its network with the establishment of subsidiaries in key regions, enhancing resource allocation and market share[98] - A new wholly-owned subsidiary, Zhongfang Biao (Jiangxi) Testing Co., Ltd., was established during the reporting period, expanding the company's control over its operations[115] Research and Development - In 2022, Chinatesta published two national standard samples for textile testing, enhancing its product offerings and compliance standards[3] - The company has published 41 standards, including 3 international standards, demonstrating its commitment to standardization and quality assurance in the textile industry[50] - The company is actively participating in international standardization efforts, which enhances its competitive edge in the global market[50] - The total number of R&D personnel increased from 147 to 175, representing a growth rate of 19.05%[106] - The proportion of R&D personnel in the total workforce rose from 26.30% to 28.93%[106] - The company owns 111 patents, up from 101 in the previous period, indicating a growth of 9.90%[107] - The number of invention patents increased from 6 to 7, reflecting a growth of 16.67%[107] - The company is actively developing new testing technologies, with CNY 7,508,459.70 invested in the project during the reporting period[88] Market Conditions and Risks - The company is facing risks related to macroeconomic fluctuations and increased competition in the textile inspection market, which could impact revenue growth[10] - Chinatesta's financial performance is closely tied to the textile industry's economic conditions, with potential revenue declines if the industry faces downturns[11] - Increased competition in the textile testing market from foreign institutions and numerous domestic private firms poses a challenge to the company's performance[133] - The textile inspection industry is expected to see increased market concentration, leading to a competitive environment where only the strongest will thrive[124] - The company faces risks from macroeconomic fluctuations and changes in industry policies that could slow demand for inspection and certification services[132] Sustainability and Social Responsibility - The company received the Green Product Certification in December 2022, reflecting its commitment to sustainability[4] - The company has launched multiple certification projects, including "green fibers" and "biodegradable products," to promote sustainable practices in the textile industry[121] - The company generated energy-saving and environmental protection expenses of CNY 596,200 for waste liquid treatment in the reporting period[122] - The company has invested over 50,000 yuan in agricultural products to support poverty alleviation and rural revitalization efforts[116] - The company has been actively involved in social responsibility, supporting emergency relief efforts during natural disasters and providing strong technical support for government and military material inspections[117] - During the 2022 Winter Olympics, the company developed testing and evaluation plans for uniforms and equipment, ensuring quality assurance for Olympic apparel[118] Future Plans and Strategic Initiatives - The company plans to continue expanding its inspection and certification services in the textile and light industry[26] - Future plans include advancing standard project development and participating in international standardization efforts to support technological innovation[127] - The company aims to enhance its market share and competitive advantage through technological innovation and differentiated service capabilities[126] - The company will pursue both internal growth and external acquisitions to achieve limited diversification and strengthen its market position[126] - Future plans include expanding inspection and testing, certification, standard services, and measurement businesses, while actively pursuing external acquisition projects for diversified growth[128] - The company aims to enhance business collaboration across sectors, particularly in high-performance materials and textile additives[128] - Digital transformation efforts will focus on optimizing core business systems and developing a comprehensive digital platform to drive data utilization[128] Shareholder and Governance Matters - The largest shareholder, China Textile Science Research Institute Co., Ltd., holds 54,000,000 shares, representing 58.37% of the total shares[166] - The second-largest shareholder, Shenzhen Aixin Industrial Development Co., Ltd., holds 7,752,403 shares, representing 8.38% of the total shares[166] - The company has committed to avoiding competition and conflicts of interest among its directors and major shareholders[156] - The company has made commitments regarding share lock-up and price stabilization measures to protect investor interests[158] - The company has appointed two new independent directors, Wang Yuping and Wang Jinfeng, due to plans to apply for listing on the Beijing Stock Exchange[197] - The independent directors' remuneration is set at 60,000 yuan per year, approved by the board on January 18, 2022[200]

申万宏源证券承销保荐有限责任公司 关于中纺标检验认证股份有限公司 2022 年度募集资金存放与使用情况的专项核查报告 申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"， "保荐机构"）作为中纺标检验认证股份有限公司（以下简称"中纺标"或"公 司"〉向不特定合格投资者公开发行股票并在北交所上市的保荐机构，根据《证 券发行上市保荐业务管理办法》《上市公司监管指引第 号一上市公司募集资金 管理和使用的监管要求》《北京证券交易所上市公司持续监管办法（试行）》《北 京证券交易所证券发行上市保荐业务管理细则》等有关规定，对中纺标 2022 度募集资金存放与使用情况进行了核查，具体情况如下： 一、募集资金基本情况 （一）新三板挂牌期间募集资金基本情况 019 12 日公司召开第一届董事会第十三次会议，审议通过《2019 第一次股票发行方案》，该议案于 2019 年第三次临时股东大会审议通过。经全国 中小企业股份转让系统《关于中纺标检验认证股份有限公司股票发行股份登记的 函》（股转系统函［2020]1209 号）确认，公司发行 13,808,644 股。此次股票发行 价格为人民币 4.39 元／股，募集资金总额 ...

公司控股股东持有的本公司股份不存在被冻结及股权质押的情形。公司不存 在控股子公司持有本公司股份的情形。 二、内部制度建设情况 经核查,公司已按照《北京证券交易所股票上市规则（试行）》等业务规则 完善公司章程,建立了"三会议事规则"、《对外投资管理制度》《对外担保管 理制度》《关联交易管理制度》《投资者关系管理制度》《利润分配管理制度》 《承诺管理制度》《信息披露管理制度》《资金管理制度》《印鉴管理制度》《内 幕知情人登记管理制度》《董事会秘书工作规则》《独立董事工作制度》《累积 投票制实施细则》《股东大会网络投票实施细则》《总经理工作细则》《防范控 股股东及关联方资金占用专项制度》等各项内部制度,不存在应该建立而未建立 相关制度的情形。 三、机构设置情况 申万宏源证券承销保荐有限责任公司 关于中纺标检验认证股份有限公司 治理专项自查及规范活动的专项核查报告 申万宏源证券承销保荐有限责任公司(以下简称"申万宏源承销保荐"或"保 荐机构")作为中纺标检验认证股份有限公司(以下简称"中纺标"或"公司")的保 荐机构,根据《关于做好上市公司 2022 年年度报告披露相关工作的通知》(北证 办发(2022)62号)(以 ...

Financial Performance - Operating revenue for Q1 2023 was CNY 35,892,047.62, representing a year-on-year increase of 15.78%[11] - Net profit attributable to shareholders for Q1 2023 was CNY 763,437.95, a decrease of 20.69% compared to the same period last year[11] - Cash flow from operating activities for Q1 2023 was CNY 3,514,839.27, down 48.92% year-on-year[12] - The company's gross profit margin decreased due to a 25.07% increase in operating costs, which reached CNY 21,615,000[13] - Total operating revenue for Q1 2023 reached ¥35,892,047.62, an increase of 15.5% compared to ¥31,000,067.49 in Q1 2022[41] - Net profit for Q1 2023 was ¥9,348.59, a decrease of 98.2% from ¥516,887.58 in Q1 2022[42] - Operating profit for Q1 2023 was ¥85,867.50, a decrease of 86.0% from ¥614,109.25 in Q1 2022[42] - Basic earnings per share for Q1 2023 were ¥0.0083, down from ¥0.0117 in Q1 2022, reflecting a decline of 29.9%[43] Assets and Liabilities - Total assets as of March 31, 2023, were CNY 379,406,788.48, a decrease of 0.39% compared to the end of 2022[11] - Total current assets decreased to CNY 274,245,386.82 as of March 31, 2023, from CNY 281,732,300.42 as of December 31, 2022, representing a decline of approximately 2%[34] - Total non-current assets rose to CNY 105,161,401.66 as of March 31, 2023, compared to CNY 99,150,865.29 as of December 31, 2022, indicating an increase of approximately 6.4%[35] - Total liabilities decreased to CNY 45,581,099.30 from CNY 46,840,235.12, reflecting a reduction of about 2.7%[36] - The company's total liabilities increased to ¥19,091,729.79 in 2023 from ¥18,930,067.60 in 2022, representing a growth of 0.9%[40] Shareholder Information - The number of ordinary shareholders was 3,447 as of the report date[19] - The largest shareholder, China Textile Science Research Institute Co., Ltd., holds 54,000,000 shares, representing 58.42% of total shares[22] - The second largest shareholder, Shenzhen Aixin Pei Industrial Development Co., Ltd., holds 7,752,403 shares, accounting for 8.39% of total shares[22] - The total shares held by the top ten shareholders amount to 79,994,073, which is 86.54% of the total shares[23] Cash Flow and Investments - Cash outflow from investing activities was CNY 37,439,603.20 in Q1 2023, significantly higher than CNY 3,118,125.32 in Q1 2022[50] - Net cash flow from investing activities was negative CNY 33,286,828.31 in Q1 2023, compared to negative CNY 2,883,783.59 in Q1 2022[50] - Cash outflow from financing activities was CNY 2,800,863.42 in Q1 2023, a decrease of 54.5% from CNY 6,150,133.53 in Q1 2022[50] - The company reported a net cash decrease of CNY 32,573,974.88 in Q1 2023, compared to a decrease of CNY 2,153,358.57 in Q1 2022[50] Operational Highlights - The company reported a significant increase in prepayments, which rose by 217.48% due to purchases of office supplies and laboratory consumables[13] - Research and development expenses for Q1 2023 were ¥3,551,660.42, slightly up from ¥3,468,663.96 in Q1 2022, indicating a focus on innovation[42] - The company reported a credit impairment loss of ¥756,238.63 in Q1 2023, compared to a gain of ¥230,757.58 in Q1 2022, indicating a significant shift in credit quality[42] Compliance and Governance - The company has not reported any litigation or arbitration matters during the reporting period[27] - The company has not disclosed any major events or compliance issues during the reporting period[27] - The company has not engaged in any external guarantees or loans during the reporting period[27] - The company has not reported any assets being frozen, seized, or pledged[27] - The company has not faced any investigations or penalties during the reporting period[27] - The company has committed to protecting investor interests by adhering to share lock-up agreements and other commitments related to the public offering[30]